MRNA Vaccine Technology Beyond COVID-19.

ABSTRACT:

Background/objectives

Since their approval in early 2020, mRNA vaccines have gained significant attention since the COVID-19 pandemic as a potential therapeutic approach to tackle several infectious diseases. This article aims to review the current state of mRNA vaccine technology and its use against other diseases.

Methods

To obtain accurate and reliable data, we carefully searched the clinicaltrial.gov and individual companies' websites for current ongoing clinical trials reports. Also, we accessed different NCBI databases for recent articles or reports of clinical trials, innovative design of mRNA vaccines, and reviews.

Results

Significant progress has been made in the design and improvement of mRNA vaccine technology. Currently, there are hundreds of ongoing clini

SUBMITTER: Oloruntimehin S 

PROVIDER: S-EPMC12197385 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature